Circ: MI Survival with Different Repurfusion Treatments

"Five-Year Survival in Patients With ST-Segment–Elevation Myocardial Infarction According to Modalities of Reperfusion Therapy"
http://circ.ahajournals.org/content/129/16/1629.abstract
"Conclusions—In a real-world setting, on a nationwide scale, a pharmaco-invasive strategy constitutes a valid alternative to pPCI, with 5-year survival at least equivalent to that of the reference reperfusion method."